Catherine Turkel
Directeur/Membre du Conseil chez LEXARIA BIOSCIENCE CORP.
Fortune : 3 285 $ au 30/04/2024
Profil
Catherine C.
Turkel is an Independent Director at Lexaria Bioscience Corp.
and the Prostate Cancer Research Institute.
She previously worked as the Director of Drug Development & Regulatory Affairs at Cypros Pharmaceutical Corp., Vice President of Clinical Development at Allergan, Inc., Chief Development Officer at Otic Pharma Ltd., and President at Eledon Pharmaceuticals, Inc. Turkel holds an MBA from the University of California, Irvine, and doctorates from the University of the Pacific and Capella University LLC.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
LEXARIA BIOSCIENCE CORP.
0,01% | 26/04/2024 | 1 500 ( 0,01% ) | 3 285 $ | 30/04/2024 |
Postes actifs de Catherine Turkel
| Sociétés | Poste | Début |
|---|---|---|
| LEXARIA BIOSCIENCE CORP. | Directeur/Membre du Conseil | 02/09/2022 |
| Prostate Cancer Research Institute | Directeur/Membre du Conseil | - |
Anciens postes connus de Catherine Turkel
| Sociétés | Poste | Fin |
|---|---|---|
Object Pharma, Inc.
 Object Pharma, Inc. BiotechnologyHealth Technology Object Pharma, Inc developing botulinum neurotoxins for unmet needs in aesthetic and therapeutic markets. The company is headquartered in New Port Beach, California. | Directeur/Membre du Conseil | 01/04/2023 |
| ELEDON PHARMACEUTICALS, INC. | President | 30/06/2020 |
Otic Pharma Ltd.
 Otic Pharma Ltd. Pharmaceuticals: MajorHealth Technology Otic Pharma Ltd. develops and manufactures pharmaceutical products for ear indications. Its products include FoamOtic Externa, FoamOtic Sinus, Foam-O-Vet, and FoamOtic Media. The company was founded by Gad Riesenfeld, Rodrigo A. Yelin and Eran Eilat in March 2008 and is headquartered in Irvine, CA. | Corporate Officer/Principal | 01/01/2017 |
| ALLERGAN, INC. | Corporate Officer/Principal | 01/01/2015 |
| Cypros Pharmaceutical Corp. | Corporate Officer/Principal | 01/01/1998 |
Formation de Catherine Turkel
| University of the Pacific | Doctorate Degree |
| University of California, Irvine | Masters Business Admin |
| Capella University LLC | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ELEDON PHARMACEUTICALS, INC. | Health Technology |
| LEXARIA BIOSCIENCE CORP. | Health Technology |
| Entreprise privées | 5 |
|---|---|
Otic Pharma Ltd.
Otic Pharma Ltd. Pharmaceuticals: MajorHealth Technology Otic Pharma Ltd. develops and manufactures pharmaceutical products for ear indications. Its products include FoamOtic Externa, FoamOtic Sinus, Foam-O-Vet, and FoamOtic Media. The company was founded by Gad Riesenfeld, Rodrigo A. Yelin and Eran Eilat in March 2008 and is headquartered in Irvine, CA. | Health Technology |
Allergan, Inc.
 Allergan, Inc. Pharmaceuticals: MajorHealth Technology Allergan, Inc. operated as a global healthcare company. It engaged in the development and commercialization of specialty pharmaceutical, medical device ,and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological, and other specialty markets. The company was founded by Gavin S. Herbert Sr. in 1950 and headquartered in Irvine, CA. | Health Technology |
| Cypros Pharmaceutical Corp. | Health Technology |
Object Pharma, Inc.
Object Pharma, Inc. BiotechnologyHealth Technology Object Pharma, Inc developing botulinum neurotoxins for unmet needs in aesthetic and therapeutic markets. The company is headquartered in New Port Beach, California. | Health Technology |
| Prostate Cancer Research Institute |
